| |
| |
|
| Insider
Information: |
Krieg Arthur M |
| Relationship: |
Chief Scientific Officer |
| City: |
Wellesley |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
815,734 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,565,207 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
815,734 |
|
|
| Total
Value |
$8,565,207 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
9
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-9.0
|
0.0
|
| Percentage
Gain/Loss : |
 -61.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Coley Pharmaceutical Group, Inc. |
COLY |
SVP, R & D, Chief Scie... |
2008-01-04 |
0 |
2008-01-04 |
0 |
Premium* |
|
|
Checkmate Pharmaceuticals, Inc. |
CMPI |
Chief Scientific Officer |
2021-06-18 |
815,734 |
2021-05-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-06-18 |
4 |
B |
$6.04 |
$43,633 |
D/D |
7,224 |
815,734 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-06-16 |
4 |
B |
$6.18 |
$22,112 |
D/D |
3,578 |
808,510 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-05-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(205,371) |
0 |
0 |
- |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-05-18 |
4 |
B |
$6.97 |
$174,257 |
D/D |
25,001 |
804,932 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-03-29 |
4 |
AB |
$10.94 |
$370,673 |
D/D |
33,220 |
779,931 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-03-26 |
4 |
AB |
$12.15 |
$42,331 |
D/D |
3,484 |
746,711 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-03-25 |
4 |
AB |
$12.35 |
$123,945 |
D/D |
10,036 |
743,227 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-01-27 |
4 |
B |
$13.05 |
$22,198 |
D/D |
1,701 |
733,191 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-01-19 |
4 |
B |
$13.09 |
$6,545 |
D/D |
500 |
731,490 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-12-29 |
4 |
B |
$14.16 |
$6,273 |
D/D |
443 |
730,990 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-12-22 |
4 |
B |
$14.64 |
$74,708 |
D/D |
5,103 |
730,547 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-12-16 |
4 |
B |
$14.62 |
$70,249 |
D/D |
4,805 |
725,444 |
2.74 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2020-12-15 |
4 |
B |
$14.49 |
$609 |
D/D |
42 |
720,639 |
2.66 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific OfficerOffice |
• • – |
2020-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
205,371 |
|
- |
|
| CMPI |
Checkmate Pharmaceuticals... |
Chief Scientific OfficerOffice |
• • – |
2020-08-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
720,597 |
|
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2008-01-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,720) |
0 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2008-01-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(545,602) |
0 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2007-08-29 |
4 |
S |
$1.89 |
$39,822 |
D/D |
(21,070) |
545,602 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2006-12-07 |
4 |
S |
$2.24 |
$40,593 |
D/D |
(18,122) |
566,972 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2006-10-13 |
4 |
S |
$1.89 |
$24,967 |
D/D |
(13,210) |
585,094 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2006-10-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
566,672 |
0 |
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2006-05-08 |
4 |
D |
$14.34 |
$352,463 |
D/D |
(24,579) |
598,304 |
|
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R & D, Chief Scien. Off. |
• – – |
2005-11-29 |
4 |
OE |
$1.15 |
$24,150 |
D/D |
21,000 |
622,883 |
|
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R& D, Chief Scien. Off. |
• – – |
2005-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,870 |
601,883 |
|
- |
|
| COLY |
Coley Pharmaceutical Grou... |
SVP, R& D, Chief Scien. Off.Of |
• – – |
2005-08-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,720 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
